View Older Stories

Jun 2, 2026 05:03AM Praxis Precision Medicines Inc. (PRAX) PT Lowered to $810 at BTIG

Jun 1, 2026 04:15PM Praxis pauses vormatrigine study after trial misses primary endpoint

Jun 1, 2026 04:14PM Praxis Precision Medicines (PRAX) halted, news pending

May 26, 2026 06:52AM H.C. Wainwright Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX)

May 7, 2026 01:54PM Praxis Precision Medicines Inc. (PRAX) PT Raised to $550 at Jefferies

May 7, 2026 08:07AM Praxis Precision Medicines (PRAX) Tops Q1 EPS by 40c

Apr 15, 2026 09:39AM Praxis Precision Medicines Inc. (PRAX) PT Raised to $437 at Deutsche Bank

Apr 14, 2026 03:32PM Jones Trading on Praxis Precision Medicines Inc. (PRAX): 'one step closer to becoming a commercial-stage company'

Apr 14, 2026 11:46AM BTIG on Praxis Precision Medicines Inc. (PRAX): NDA acceptance offers clean regulatory setup for approval

Apr 14, 2026 11:38AM Jefferies on Praxis Precision Medicines Inc. (PRAX): 'see 5%+ stock upside as FDA accepts the NDA for ulixacaltamide'

Apr 14, 2026 07:30AM Praxis Precision Medicines receives FDA acceptance for essential tremor drug

Apr 13, 2026 05:52AM Bernstein on US Pharma and Biotech: Who might buy whom?

Apr 9, 2026 04:29PM Raymond James Starts Praxis Precision Medicines Inc. (PRAX) at Strong Buy, 'Bears Sound Smart, but Bulls Make Money'

Apr 7, 2026 07:45AM H.C. Wainwright Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX)

Apr 6, 2026 08:00AM Praxis Precision Medicines reports positive trial results for epilepsy drug

Mar 9, 2026 09:50AM BTIG Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX): "see the X-TOLE2 readout as having no readthrough"

Feb 24, 2026 08:58AM Wolfe Research Starts Praxis Precision Medicines Inc. (PRAX) at Outperform, Top Pick

Feb 19, 2026 08:48AM Truist on Praxis Precision Medicines Inc. (PRAX): 'We see Significant Upside Potential To Our Base Case'

Feb 19, 2026 07:33AM Praxis Precision Medicines (PRAX) Misses Q4 EPS by 41c

Feb 10, 2026 06:39AM Praxis Precision Medicines Inc. (PRAX) PT Raised to $800 at Guggenheim, 'PRAX remains one of our Top Picks for 2026'

Feb 2, 2026 05:51AM Wells Fargo Starts Praxis Precision Medicines Inc. (PRAX) at Equal Weight

Jan 30, 2026 06:47AM Praxis Precision Medicines Inc. (PRAX) PT Raised to $1,245 at H.C. Wainwright

Jan 28, 2026 08:52AM Praxis Precision Medicines Inc. (PRAX) PT Raised to $1,200 at Piper Sandler on 'Major Upside Potential'

Jan 23, 2026 07:00AM Piper Sandler: 'Praxis Precision Medicines Inc. (PRAX) One of Our 2026 Best-Ideas'

Jan 13, 2026 04:30PM Praxis Precision Medicines hires epilepsy expert Dr. Orrin Devinsky as head of clinical strategy

Jan 12, 2026 08:04AM Praxis plans two drug applications by mid-February, raises $1.5 billion

Jan 8, 2026 04:45PM Praxis appoints two board directors and promotes two executives

Jan 6, 2026 04:42PM After-hours movers: Strategy, Mobileye, Ventyx Bioscience, Praxis

Jan 5, 2026 07:08AM Needham Names MindMed (MNMD) New Top Pick for 2026, Adds to Conviction List

Jan 2, 2026 08:56AM TD Cowen Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX)

Dec 31, 2025 07:16AM TD Cowen: 'We view yesterday's announcement as highly positive for PRAX'

Dec 30, 2025 08:22AM Truist Reiterates 'High Conviction' Buy Rating on Praxis Precision Medicines Inc. (PRAX)

Dec 30, 2025 06:37AM H.C. Wainwright Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX)

Dec 29, 2025 09:23AM Guggenheim on Praxis Precision Medicines (PRAX): one of our Top Picks for 2026

Dec 29, 2025 08:51AM Jefferies Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX)

Dec 29, 2025 08:01AM FDA grants breakthrough therapy designation to Praxis drug for essential tremor

Dec 29, 2025 06:07AM Praxis Precision Medicines Inc. (PRAX) PT Raised to $843 (from $507) at BTIG

Dec 22, 2025 07:06AM Piper Sandler Highlights Top Picks in the Biopharma 2026 Preview Note

Dec 15, 2025 04:35AM Praxis Precision Medicines Inc. (PRAX) PT Raised to $750 (from $250) at Oppenheimer

Dec 11, 2025 08:02AM Praxis plans to file NDA for relutrigine in rare epilepsies by early 2026

Dec 9, 2025 04:01PM Praxis gets FDA agreement to simplify elsunersen trial design

Dec 8, 2025 09:18AM Praxis Precision Medicines Inc. (PRAX) PT Raised to $353 at TD Cowen

Dec 8, 2025 07:32AM Piper Sandler on Biotechnology: 'What Commercial Names to Own in 2026?'

Dec 8, 2025 07:10AM Praxis Precision Medicines Inc. (PRAX) PT Raised to $315 at Needham

Dec 8, 2025 06:30AM Praxis Precision Medicines Inc. (PRAX) PT Raised to $760 at Guggenheim, 'remains one of our top picks for 2025'

Dec 8, 2025 06:26AM Praxis Precision Medicines Inc. (PRAX) PT Raised to $500 at Truist Securities

Dec 8, 2025 06:17AM Praxis Precision Medicines (PRAX) call put ratio 1 call to 6 puts

Dec 5, 2025 07:20AM Piper Sandler on Praxis Precision Medicines (PRAX): 'Two Major Wins Set the Stage for Multiple Potential Approvals in 2026'

Dec 5, 2025 07:08AM Praxis Precision Medicines Inc. (PRAX) PT Raised to $304 at Needham

Dec 5, 2025 06:44AM Praxis Precision Medicines Inc. (PRAX) PT Raised to $340 at H.C. Wainwright

View Older Stories